2025-12-5 216.73.216.21
Code of China Chinese Classification Professional Classification ICS Classification Latest News Value-added Services

Position: Chinese Standard in English/T/SHSPTA 002-2023
T/SHSPTA 002-2023   Specification for entrusted distribution management by drug market authorization holders (English Version)
Standard No.: T/SHSPTA 002-2023 Status:valid remind me the status change

Email:

Target Language:English File Format:PDF
Word Count: Translation Price(USD): remind me the price change

Email:

Implemented on:2023-5-20 Delivery:

→ → →

,,2023-5-20,AFFDEDCDBF75A6FA1755226562438
Standard No.: T/SHSPTA 002-2023
English Name: Specification for entrusted distribution management by drug market authorization holders
Chinese Name: 药品上市许可持有人委托销售管理规范
Chinese Classification: C00    Standardization and quality management
Professional Classification: T/    Social Organization Standard
ICS Classification: 03.120.10 03.120.10    Quality management and quality assurance 03.120.10
Source Content Issued by: Shanghai Pharmaceutical Trade Association‌
Issued on: 2023-05-10
Implemented on: 2023-5-20
Status: valid
Target Language: English
File Format: PDF
本文件规定了药品上市许可持有人委托销售活动中委托方、受托方及其他相关方的职责,明确了人员、过程管理、追溯体系、质量审核、药物警戒、售后管理、应急处置、变更控制、档案管理等方面的要求。
本文件适用于药品上市许可持有人委托销售过程中所涉及的经营管理活动。
本文件亦可作为中药饮片生产企业委托销售活动的执行参考依据。
Code of China
Standard
T/SHSPTA 002-2023  Specification for entrusted distribution management by drug market authorization holders (English Version)
Standard No.T/SHSPTA 002-2023
Statusvalid
LanguageEnglish
File FormatPDF
Word Count words
Price(USD)
Implemented on2023-5-20
Deliveryvia email in business day
Detail of T/SHSPTA 002-2023
Standard No.
T/SHSPTA 002-2023
English Name
Specification for entrusted distribution management by drug market authorization holders
Chinese Name
药品上市许可持有人委托销售管理规范
Chinese Classification
C00
Professional Classification
T/
ICS Classification
Issued by
Shanghai Pharmaceutical Trade Association‌
Issued on
2023-05-10
Implemented on
2023-5-20
Status
valid
Superseded by
Superseded on
Abolished on
Superseding
Language
English
File Format
PDF
Word Count
words
Price(USD)
Keywords
T/SHSPTA 002-2023, T/SHSPTAT 002-2023, TSHSPTAT 002-2023, T/SHSPTA002-2023, T/SHSPTA 002, T/SHSPTA002, T/SHSPTAT002-2023, T/SHSPTAT 002, T/SHSPTAT002, TSHSPTAT002-2023, TSHSPTAT 002, TSHSPTAT002
Introduction of T/SHSPTA 002-2023
本文件规定了药品上市许可持有人委托销售活动中委托方、受托方及其他相关方的职责,明确了人员、过程管理、追溯体系、质量审核、药物警戒、售后管理、应急处置、变更控制、档案管理等方面的要求。
本文件适用于药品上市许可持有人委托销售过程中所涉及的经营管理活动。
本文件亦可作为中药饮片生产企业委托销售活动的执行参考依据。
Contents of T/SHSPTA 002-2023
About Us   |    Contact Us   |    Terms of Service   |    Privacy   |    Cancellation & Refund Policy   |    Payment
Tel: +86-10-8572 5655 | Fax: +86-10-8581 9515 | Email: coc@codeofchina.com | QQ: 672269886
Copyright: Beijing COC Tech Co., Ltd. 2008-2040
 
 
Keywords:
T/SHSPTA 002-2023, T/SHSPTAT 002-2023, TSHSPTAT 002-2023, T/SHSPTA002-2023, T/SHSPTA 002, T/SHSPTA002, T/SHSPTAT002-2023, T/SHSPTAT 002, T/SHSPTAT002, TSHSPTAT002-2023, TSHSPTAT 002, TSHSPTAT002